Gennex Laboratories Limited (BSE: 531739)
Health Care · Pharmaceuticals · IN
Rs9.61
-1.94% today · -21.2% 1Y
Gennex Laboratories Limited (BSE: 531739) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.12M.
Over the last twelve months the share price has lost 21.2%, trading between 7.05 and 17.25.
Tweenvest scores Gennex Laboratories Limited across four factors: quality 65/100, value 70/100, growth 85/100. Its strongest factor is growth.
531739 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.12M
- Revenue (TTM)
- $18.87M
- P/E
- 12.96
- EPS
- 0.74
- Dividend yield
- —
- Beta (5Y)
- 1.06
- 52-week high
- Rs17.25
- 52-week low
- Rs7.05
- Avg volume (3M)
- —
- Shares outstanding
- 242.95M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.91M | NT$18.80 | +1.90% |
| iAnthus Capital Holdings, Inc.CNSX: IAN | $24.44M | CA$0.01 | -50.00% |
| Orexo AB (publ)OM: ORX | $24.32M | Skr6.19 | -5.93% |
| Everest Organics LimitedBSE: 524790 | $24.15M | Rs240.65 | +9.49% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| TherapeuticsMD, Inc.NasdaqGS: TXMD | $23.84M | $2.02 | -1.94% |
| Quantum BioPharma Ltd.NasdaqCM: QNTM | $23.78M | $2.80 | -4.76% |
| Emyria LimitedASX: EMD | $23.64M | AU$0.04 | -6.67% |
Figures last refreshed Oct 11, 2026.